SD Biosensor, Inc. Overview
Pro stress-test →SD Biosensor is a global in-vitro diagnostic (IVD) company headquartered in Suwon, South Korea that designs, manufactures, and distributes point-of-care diagnostic solutions. The company provides comprehensive diagnostic platforms spanning rapid immunochemical tests, molecular diagnostics, fluorescence immunoassay systems, and blood glucose monitoring devices for healthcare providers and patients globally.
Strategic Profile
Pro stress-test →SD Biosensor operates a diversified product portfolio including STANDARD Q (rapid diagnostics), STANDARD F (laboratory FIA systems), STANDARD M (point-of-care molecular diagnostics), and blood glucose monitoring solutions. The company maintains a strong international presence with subsidiaries across the USA, Brazil, Germany, Italy, Spain, India, and Indonesia, positioning itself as a leading global IVD provider serving both developed and low-to-middle income countries.
Competitive Landscape
Pro stress-test →SD Biosensor competes in the global IVD market against multinational giants (Abbott, Roche, Siemens, Bio-Rad) and regional players. The company differentiates through point-of-care solutions, emerging market focus, and platform technology. Competitive advantages include rapid product development, global distribution network, and lower-cost solutions suited for resource-constrained settings.
Industry Context
SD Biosensor, Inc. operates in In-Vitro Diagnostics (IVD) - Medical Devices & Healthcare.
Key facts
Founded: 2010 · Headquarters: Suwon, South Korea · Employees: 649 · Revenue: $494M · Market cap: $848M